Multiple Sclerosis is an inflammatory disease of brain and spinal cord where the insulating covers of nerve cells are damaged. It is an autoimmune disorder that affects the central nervous system. It may be caused by geography, genetics, infectious agents and others. Symptoms include weakness, tingling, numbness and blurred vision. Drugs that are used for treatment are interferon beta-1a (Avonex, Rebif), peginterferon beta-1a (Plegridy), teriflunomide (Aubagio), fingolimod (Gilenya), mitoxantrone (Novantrone), dimethyl fumarate (Tecfidera) and natalizumab (Tysabri).
Related Journals of Multiple Sclerosis
Spine, Spine & Neurosurgery, Clinical & Experimental Neuroimmunology, Neuroinfectious Diseases, Multiple Sclerosis,Multiple Sclerosis and Related Disorders, Consortium of Multiple Sclerosis Centers (CMSC), Therapeutic Advances in Neurological Disorders, CNS and Neurological Disorders- Drug Targets, Current Drug Targets: CNS and Neurological Disorders
Neurological Disorders received 1343 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
